Kati Donner

Kati Donner

Auto-generated profile, based on publicly available information

Kati Donner

Department of Medicine, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1999 in Nature Genetics
Verified
Journal Article
Closed access
KNKristen J. Nowak
Kristen J. Nowak
DWDuangrurdee Wattanasirichaigoon
Duangrurdee Wattanasirichaigoon
HGHans H. Goebel
Hans H. Goebel
MWMatthew Wilce
Matthew Wilce
KPKatarina Pelin
Katarina Pelin
NLNigel George Laing
Nigel George Laing

2 March 1999 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KPKatarina Pelin
Katarina Pelin
PHPirta Hilpelä
Pirta Hilpelä
KDKati Donner
Kati Donner
CSCaroline Sewry
Caroline Sewry
PAPatrick A. Akkari
Patrick A. Akkari
CWCarina Wallgren-Pettersson
Carina Wallgren-Pettersson
The congenital nemaline myopathies are rare hereditary muscle disorders characterized by the presence in the muscle fibers of nemaline bodies consisting of proteins derived from the Z disc and thin filament. In a single large Australian family with an autosomal dominant form of nemaline myopathy, the disease is caused by a mutation in the α-tropomyosin gene TPM3 . The typical form of nemaline myopathy is inherited as an autosomal recessive trait, the locus of which we previously assigned to chromosome 2q21.2-q22. We show here that mutations in the nebulin gene located within this region are associated with the disease. The nebulin protein is a giant protein found in the thin filaments of striated muscle. A variety of nebulin isoforms are thought to contribute to the molecular diversity of Z discs. We have studied the 3′ end of the 20.8-kb cDNA encoding the Z disc part of the 800-kDa protein and describe six disease-associated mutations in patients from five families of different ethnic origins. In two families with consanguineous parents, the patients were homozygous for point mutations. In one family with nonconsanguineous parents, the affected siblings were compound heterozygotes for two different mutations, and in two further families with one detected mutation each, haplotypes are compatible with compound heterozygosity. Immunofluorescence studies with antibodies specific to the C-terminal region of nebulin indicate that the mutations may cause protein truncation possibly associated with loss of fiber-type diversity, which may be relevant to disease pathogenesis.

1 February 2002 in Neuromuscular Disorders
Verified
Journal Article
Closed access
KDKati Donner
Kati Donner
MOMiina Ollikainen
Miina Ollikainen
MRMaaret Ridanpää
Maaret Ridanpää
HCHans-Jürgen Christen
Hans-Jürgen Christen
HGHans H Goebel
Hans H Goebel
CWCarina Wallgren-Pettersson
Carina Wallgren-Pettersson

17 August 2006 in Human Mutation
Verified
Journal Article
Closed access
PDF file
VLVilma-Lotta Lehtokari
Vilma-Lotta Lehtokari
KPKatarina Pelin
Katarina Pelin
MSMaria Sandbacka
Maria Sandbacka
SRSalla Ranta
Salla Ranta
KDKati Donner
Kati Donner
CWCarina Wallgren-Pettersson
Carina Wallgren-Pettersson
Nemaline myopathy (NM) is a clinically and genetically heterogeneous disorder of skeletal muscle caused by mutations in at least five different genes encoding thin filament proteins of the striated muscle sarcomere. We have previously described 18 different mutations in the last 42 exons of the nebulin gene (NEB) in 18 families with NM. Here we report 45 novel NEB mutations detected by denaturing high‐performance liquid chromatography (dHPLC) and sequence analysis of all 183 NEB exons in NM patients from 44 families. Altogether we have identified, including the deletion of exon 55 identified in the Ashkenazi Jewish population, 64 different mutations in NEB segregating with autosomal recessive NM in 55 families. The majority (55%) of the mutations in NEB are frameshift or nonsense mutations predicted to cause premature truncation of nebulin. Point mutations (25%) or deletions (3%) affecting conserved splice signals are predicted in the majority of cases to cause in‐frame exon skipping, possibly leading to impaired nebulin–tropomyosin interaction along the thin filament. Patients in 18 families had one of nine missense mutations (14%) affecting conserved amino acids at or in the vicinity of actin or tropomyosin binding sites. In addition, we found the exon 55 deletion in four families. The majority of the patients (in 49/55 families) were shown to be compound heterozygous for two different mutations. The mutations were found in both constitutively and alternatively expressed exons throughout the NEB gene, and there were no obvious mutational hotspots. Patients with more severe clinical pictures tended to have mutations predicted to be more disruptive than patients with milder forms. Hum Mutat 27(9), 946–956, 2006. Published 2006 Wiley‐Liss, Inc.

21 July 2004 in European Journal of Human Genetics
Verified
Journal Article
Closed access
KDKati Donner
Kati Donner
MSMaria Sandbacka
Maria Sandbacka
VLVilma-Lotta Lehtokari
Vilma-Lotta Lehtokari
CWCarina Wallgren-Pettersson
Carina Wallgren-Pettersson
KPKatarina Pelin
Katarina Pelin

1 August 2013 in Hypertension
Verified
Journal Article
Closed access
PDF file
STStephen T. Turner
Stephen T. Turner
EBEric Boerwinkle
Eric Boerwinkle
JOJeffrey R. O’connell
Jeffrey R. O’connell
KBKent R. Bailey
Kent R. Bailey
YGYan Gong
Yan Gong
JJJulie A. Johnson
Julie A. Johnson
To identify novel genes influencing blood pressure response to thiazide diuretic therapy for hypertension, we conducted genome-wide association meta-analyses of ≈1.1 million single-nucleotide polymorphisms in a combined sample of 424 European Americans with primary hypertension treated with hydrochlorothiazide from the Pharmacogenomic Evaluation of Antihypertensive Responses study (n=228) and the Genetic Epidemiology of Responses to Antihypertensive study (n=196). Polymorphisms associated with blood pressure response at P 4/4 mm Hg) across study samples. The rs2273359 polymorphism in the GNAS-EDN3 region also replicated for same-direction association with systolic blood pressure response in the Nordic Diltiazem study, and the combined 3-study meta-analysis P value approached genome-wide significance ( P =5.5×10 −8 ). The findings document clinically important effects of genetic variation at novel loci on blood pressure response to a thiazide diuretic, which may be a basis for individualization of antihypertensive drug therapy and identification of new drug targets.